Home › Funds › Sarissa Capital Management LP › IRWD

Sarissa Capital Management LP position in IRWD

IRONWOOD PHARMACEUTICALS INC · Health Care

Sarissa Capital Management LP reported holding 9,188,635 shares of IRWD (IRONWOOD PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$38.7M, representing 21.75% of its reported portfolio and ranking #2 among its reported holdings. Sarissa Capital Management LP has disclosed IRWD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)9.19M sh
Reported value held$38.68M
Portfolio Weight21.75%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sarissa Capital Management LP's IRWD position evolved

Sarissa Capital Management LP first disclosed a stake in IRWD in Q3 2023 at 16,390,000 shares (US$157.8M). The position peaked in Q4 2023 at 16,390,000 shares, worth US$187.5M. Across 12 filings, Sarissa Capital Management LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 9,188,635 shares valued at US$38.7M. Notable position changes include a 42% trim in Q1 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.39M $157.84M New
Q4 2023 16.39M $187.50M Hold
Q1 2024 16.39M $142.76M Hold
Q2 2024 16.39M $106.86M Hold
Q3 2024 16.39M $67.53M Hold
Q4 2024 16.39M $72.61M Hold
Q1 2025 16.39M $24.09M Hold
Q2 2025 15.92M $11.42M Reduce
Q3 2025 15.92M $20.85M Hold
Q4 2025 15.92M $53.65M Hold
Q1 2026 9.19M $32.25M Reduce
Q2 2026 9.19M $38.68M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRWD and 13F data

IRWD (IRONWOOD PHARMACEUTICALS INC) is a Health Care company. 24 other funds we track also report a position in IRWD — the largest reported positions include ARMISTICE CAPITAL, LLC (US$58.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRWD

All IRWD fund holders →

FAQ

How long has Sarissa Capital Management LP held IRWD?

Sarissa Capital Management LP has disclosed IRWD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Sarissa Capital Management LP's current position in IRWD?

As of Q2 2026, Sarissa Capital Management LP holds 9.19M shares of IRWD (IRONWOOD PHARMACEUTICALS INC), valued at $38.68M, representing 21.75% of its reported portfolio and ranking #2.

Has Sarissa Capital Management LP been buying or selling IRWD?

In the latest 13F filing (Q2 2026), Sarissa Capital Management LP held unchanged its position in IRWD. The position peaked in Q4 2023 at 16.39M shares.

Which other funds hold IRWD?

Other major institutional holders of IRWD include ARMISTICE CAPITAL, LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.